[1]
2026. ASSESSMENT OF PTEN TUMOR SUPPRESSOR PROTEIN BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIAS VERSUS CARCINOMAS OVER A FOUR-YEAR PERIOD. Asian Journal of Medical Research and Health Sciences. 4, 2 (Jun. 2026), 1212–1216.